AVDL - Avadel Pharmaceuticals plc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
1.5200
0.0000 (0.00%)
As of 1:50PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close1.5200
Open1.5007
Bid1.5100 x 900
Ask1.5300 x 800
Day's Range1.4720 - 1.5700
52 Week Range1.0300 - 7.9700
Volume72,920
Avg. Volume209,501
Market Cap56.78M
Beta (3Y Monthly)1.50
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Introducing Avadel Pharmaceuticals (NASDAQ:AVDL), The Stock That Tanked 82%
    Simply Wall St.16 days ago

    Introducing Avadel Pharmaceuticals (NASDAQ:AVDL), The Stock That Tanked 82%

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Even the best investor on earth makes unsuccessful investments. But it would be foolish to simply...

  • Associated Press16 days ago

    Avadel: 1Q Earnings Snapshot

    The Dublin-based company said it had a loss of 35 cents per share. The specialty pharmaceutical company posted revenue of $16.4 million in the period. The company's shares closed at $1.20. A year ago, ...

  • Jazz's Xyrem Follow-On Drug Succeeds in Phase III Study
    Zacks2 months ago

    Jazz's Xyrem Follow-On Drug Succeeds in Phase III Study

    Jazz Pharmaceuticals (JAZZ) announced positive top-line data from its phase III study on low sodium formulation of Xyrem, JZP-258.

  • Jazz Pharmaceuticals' Sleep Drug NDA Awaits FDA Decision
    Zacks2 months ago

    Jazz Pharmaceuticals' Sleep Drug NDA Awaits FDA Decision

    The FDA will provide its decision on Jazz's (JAZZ) candidate, solriamfetol, for excessive daytime sleepiness with narcolepsy on Wednesday.

  • Associated Press2 months ago

    Avadel: 4Q Earnings Snapshot

    The Dublin-based company said it had a loss of $1.72 per share. The specialty pharmaceutical company posted revenue of $20.9 million in the period. For the year, the company reported a loss of $95.3 million, ...

  • Read This Before Selling Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares
    Simply Wall St.4 months ago

    Read This Before Selling Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. Unfortunately, there are also plenty of examples of share prices Read More...

  • Jazz (JAZZ) Falls as Sleep Drug Gets Extended Review From FDA
    Zacks5 months ago

    Jazz (JAZZ) Falls as Sleep Drug Gets Extended Review From FDA

    Jazz (JAZZ) announces that the FDA has extended the review period of its new drug application for sleep drug, solriamfetol, by three months to Mar 20, 2019.

  • Associated Press7 months ago

    Avadel: 3Q Earnings Snapshot

    The Dublin-based company said it had a loss of 43 cents per share. The specialty pharmaceutical company posted revenue of $19.8 million in the period. Avadel expects full-year revenue in the range of $90 ...

  • Brandes Investments Expands Stake in Avadel Pharmaceuticals
    GuruFocus.com9 months ago

    Brandes Investments Expands Stake in Avadel Pharmaceuticals

    The firm founded Charles Brandes (Trades, Portfolio), Brandes Investment Partners, on Thursday announced that it expanded its position in Avadel Pharmaceuticals Plc (AVDL) to 13.5% of the company, enlarging its exposure to health care, the second-largest sector represented in its portfolio. Warning! GuruFocus has detected 8 Warning Signs with PFE. The value investing firm has been building its stake in Avadel as the company's stock price has declined.

  • Associated Press10 months ago

    Avadel: 2Q Earnings Snapshot

    On a per-share basis, the Dublin-based company said it had a loss of 9 cents. The specialty pharmaceutical company posted revenue of $29.2 million in the period. Avadel shares have declined 27 percent ...

  • Should You Expect Avadel Pharmaceuticals plc (NASDAQ:AVDL) To Continue Delivering An ROE Of 34.61%?
    Simply Wall St.11 months ago

    Should You Expect Avadel Pharmaceuticals plc (NASDAQ:AVDL) To Continue Delivering An ROE Of 34.61%?

    This analysis is intended to introduce important early concepts to people who are starting to invest and looking to gauge the potential return on investment in Avadel Pharmaceuticals plc (NASDAQ:AVDL).Read More...